А. Н. Бойко

1.5k total citations
75 papers, 995 citations indexed

About

А. Н. Бойко is a scholar working on Pathology and Forensic Medicine, Neurology and Neurology. According to data from OpenAlex, А. Н. Бойко has authored 75 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 13 papers in Neurology. Recurrent topics in А. Н. Бойко's work include Multiple Sclerosis Research Studies (34 papers), Neurological Disorders and Treatments (11 papers) and Cytokine Signaling Pathways and Interactions (9 papers). А. Н. Бойко is often cited by papers focused on Multiple Sclerosis Research Studies (34 papers), Neurological Disorders and Treatments (11 papers) and Cytokine Signaling Pathways and Interactions (9 papers). А. Н. Бойко collaborates with scholars based in Russia, United Kingdom and United States. А. Н. Бойко's co-authors include A. Dessa Sadovnick, D. W. Paty, V. Devonshire, Galina Vorobeychik, О. О. Фаворова, О. Г. Кулакова, Eva Havrdová, Basil Sharrack, Sámuel Komoly and Massimo Filippi and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

А. Н. Бойко

66 papers receiving 946 citations

Peers

Countries citing papers authored by А. Н. Бойко

Since Specialization

Citations

This map shows the geographic impact of А. Н. Бойко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. Н. Бойко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. Н. Бойко more than expected).

Fields of papers citing papers by А. Н. Бойко

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. Н. Бойко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. Н. Бойко. The network helps show where А. Н. Бойко may publish in the future.

Co-authorship network of co-authors of А. Н. Бойко

This figure shows the co-authorship network connecting the top 25 collaborators of А. Н. Бойко. A scholar is included among the top collaborators of А. Н. Бойко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. Н. Бойко. А. Н. Бойко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New approaches and technologies of staffing state civil service 2024 ·А. Н. Бойко, (unknown)	0
2	Молекулярно-генетические основы рассеянного склероза: ассоциация вариантов митохондриального генома с первично-прогрессирующей формой заболевания 2020 ·Молекулярная биология ·(unknown), О. Г. Кулакова, (unknown), А. Н. Бойко, О. О. Фаворова	2
3	Вариабельность гена MIR196A2 как фактор риска развития первично-прогрессирующего рассеянного склероза 2019 ·Молекулярная биология ·И. С. Киселев, О. Г. Кулакова, Natalia Baulina, (unknown), Е. В. Попова, А. Н. Бойко, О. О. Фаворова	3
4	Immune Reconstitution Inflammatory Syndrome and Rebound Syndrome on Withdrawal of Immunomodulatory Drugs for Multiple Sclerosis: Current Understanding and a Case Report 2018 ·Neuroscience and Behavioral Physiology ·Evgenia Belova, (unknown), (unknown), (unknown), А. Н. Бойко	0
5	Disease-modifying drugs in pediatric patients with multiple sclerosis 2016 ·S S Korsakov Journal of Neurology and Psychiatry ·Bykova Ov, (unknown), (unknown), (unknown), (unknown), А. Н. Бойко	1
6	The results of an open prospective study of β-interferon biosimilars (an Yaroslavl’ cohort) 2016 ·S S Korsakov Journal of Neurology and Psychiatry ·(unknown), Н. А. Спирин, А. Н. Бойко, (unknown), (unknown), Natalia Baranova	6
7	Recommendations on the algorithms for drug choice and risk management plan in the treatment of patients with remitting multiple sclerosis with natalizumab 2016 ·S S Korsakov Journal of Neurology and Psychiatry ·(unknown), (unknown), E. P. Evdoshenko, И. П. Пронин, А. Н. Бойко, М. Н. Захарова, В. М. Алифирова, (unknown), N A Malkova, С А Сиверцева, (unknown), А. А. Скоромец, (unknown)	6
8	A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis 2016 ·S S Korsakov Journal of Neurology and Psychiatry ·(unknown), (unknown), (unknown), А. Н. Бойко	1
9	Effect of pregnancy on the course of multiple sclerosis 2015 ·SHILAP Revista de lepidopterología ·(unknown), А. Н. Бойко, Е. В. Попова, (unknown)	0
10	Dopamine receptor agonists: new forms and new possibilities in the treatment of Parkinson’s disease 2015 ·S S Korsakov Journal of Neurology and Psychiatry ·Е А Катунина, Nataliya Titova, (unknown), (unknown), (unknown), (unknown), А. В. Лебедева, А. Н. Бойко	1
11	EARLY DIFFERENTIAL DIAGNOSTICS AND PROLONGED IMMUNOMODULATORY THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING DISEASES OF CENTRAL NERVOUS SYSTEM IN CHILDREN AND ADOLESCENTS 2009 ·SHILAP Revista de lepidopterología ·Bykova Ov, (unknown), (unknown), (unknown), (unknown), А. Н. Бойко	2
12	Применение церетона у больных с умеренными когнитивными расстройствами сосудистого генеза 2009 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), А. Н. Бойко	1
13	Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study 2008 ·The Lancet ·Giacomo P. Comi, Annalisa Pulizzi, Marco Rovaris, Oded Abramsky, T. Arbizu, А. Н. Бойко, Ralf Gold, Eva Havrdová, Sámuel Komoly, Krzysztof Selmaj, Basil Sharrack, Massimo Filippi	214
14	Use of the new levodopa agent Stalevo (levodopa/carbidopa/entacapone) in the treatment of Parkinson's disease in out-patient clinical practice (the START-M open trial) 2008 ·Neuroscience and Behavioral Physiology ·А. Н. Бойко, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	9
15	Characteristics of the formation of chronic fatigue syndrome and approaches to its treatment in young patients with focal brain damage 2007 ·Neuroscience and Behavioral Physiology ·А. Н. Бойко, (unknown), (unknown), (unknown), Е. И. Гусев	3
16	Monitoring of Neurological Deficit and Disturbances in Higher Nervous Activity in Rats with Focal Cerebral Ischemia 2003 ·Bulletin of Experimental Biology and Medicine ·В. П. Чехонин, С. В. Лебедев, (unknown), Д. В. Блинов, (unknown), А. Н. Бойко, M. Yu. Martynov, Е. И. Гусев	2
17	[Mechanisms of development of neurodegenerative processes in multiple sclerosis: neuroprotective influence of beta-interferons today and neurotrophic factors -- tomorrow]. 2003 ·PubMed ·А. Н. Бойко, (unknown), (unknown), Eugene Gusev	2
18	Early onset multiple sclerosis 2002 ·Neurology ·А. Н. Бойко, Galina Vorobeychik, D. W. Paty, V. Devonshire, A. Dessa Sadovnick	312
19	Epidemiology of multiple sclerosis in Russia and other countries of the former Soviet Union: investigations of environmental and genetic factors 1995 ·Acta Neurologica Scandinavica ·А. Н. Бойко, (unknown), О. О. Фаворова, Eugene Gusev, М. А. Судомоина, Regina L. Turetskaya	20
20	[Study of cellular immunity and the opioid peptide system in patients with multiple sclerosis]. 1990 ·PubMed ·(unknown), А. Н. Бойко, (unknown), Konstantin Balashov, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact